TG Therapeutics (TGTX) Interest Coverage Ratio: History & Chart

TG Therapeutics, Inc.(TGTX)

Biotechnology · Morrisville, NY

$51.91-2.00 (-3.72%)

Delayed quote: Oct 6, 2026, 3:40 PM EDT

About TG Therapeutics, Inc.

Based in New York City and established in 1993, TG Therapeutics, Inc. is a biopharmaceutical company that has advanced to the commercial stage. Its core mission revolves around the acquisition, advancement, and marketing of novel therapeutic solutions. The company's focus areas specifically include B-cell related cancers (malignancies) and various autoimmune disorders. Among its significant investigational therapeutic candidates is Ublituximab, a distinctive glycoengineered monoclonal antibody currently undergoing evaluation. It targets B-cell non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and the relapsing forms of multiple sclerosis. Another compound in its pipeline is Umbralisib, an orally administered inhibitor designed to block PI3K-delta and CK1-epsilon enzymes. This treatment is being investigated for its effectiveness against CLL, marginal zone lymphoma, and follicular lymphoma. TG Therapeutics is also developing Cosibelimab, an IgG1 human monoclonal antibody that functions by binding to programmed death-ligand 1 (PD-L1) and subsequently preventing its interaction with PD-1 and B7.1 receptors. Furthermore, the company is advancing TG-1701, an oral, covalently-bound Bruton's tyrosine kinase (BTK) inhibitor, notably more selective for BTK compared to ibrutinib in laboratory screenings. Completing this clinical-stage portfolio is TG-1801, a bispecific antibody engineered to simultaneously target CD47 and CD19. Beyond its clinical-stage assets, the company possesses various licensed preclinical programs, including those addressing BET, interleukin-1 receptor associated kinase-4, and GITR. To enhance its research and development capabilities, TG Therapeutics has forged collaboration agreements with entities such as Checkpoint Therapeutics, Inc., Jiangsu Hengrui Medicine Co., Novimmune SA, Ligand Pharmaceuticals Incorporated, and Jubilant Biosys. The company also maintains strategic alliances with partners including LFB Biotechnologies S.A.S, GTC Biotherapeutics, LFB/GTC LLC, Ildong Pharmaceutical Co. Ltd., and Rhizen Pharmaceuticals, S A.

Morrisville, NY

399 employees

www.tgtherapeutics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Michael S. Weiss

View full financials

TGTX Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

4.61x

INTEREST COVERAGE RATIO AVG TTM

4.63x

INTEREST COVERAGE RATIO AVG 3Y

3.56x

INTEREST COVERAGE RATIO AVG 5Y

-5.09x

INTEREST COVERAGE RATIO AVG 10Y

-24.27x

INTEREST COVERAGE RATIO AVG 15Y

-29.36x

INTEREST COVERAGE RATIO AVG 20Y

-25.62x

CURRENT VS TTM AVG

-0.36%

CURRENT VS 3Y AVG

+29.59%

CURRENT VS 5Y AVG

+190.54%

CURRENT VS 10Y AVG

+119.00%

CURRENT VS 15Y AVG

+115.70%

CURRENT VS 20Y AVG

+118.00%

SECTOR MEDIAN · HEALTHCARE

-6.38x

median of 528 covered companies

CURRENT VS SECTOR MEDIAN

+172.31%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
TG Therapeutics, Inc. (TGTX)	$7.95B	4.61x	4.63x	3.56x	-5.09x
Caris Life Sciences, Inc. (CAI)vs ›	$7.75B	0.79x	0.79x	0.79x	1.52x
Praxis Precision Medicines, Inc. (PRAX)vs ›	$7.61B	N/A	N/A	N/A	N/A
HealthEquity, Inc. (HQY)vs ›	$7.61B	5.64x	4.71x	3.13x	2.65x
Cytokinetics, Incorporated (CYTK)vs ›	$7.60B	-5.89x	8.36x	8.36x	8.36x
Hinge Health, Inc. (HNGE)vs ›	$7.57B	N/A	N/A	N/A	N/A
Oscar Health, Inc. (OSCR)vs ›	$8.39B	-22.52x	2.41x	2.41x	2.41x
Kymera Therapeutics, Inc. (KYMR)vs ›	$8.61B	-1403.21x	N/A	N/A	N/A
Ionis Pharmaceuticals, Inc. (IONS)vs ›	$7.25B	-4.22x	7.50x	4.09x	4.09x
Arrowhead Pharmaceuticals, Inc. (ARWR)vs ›	$8.63B	1.10x	1.10x	1.10x	1.10x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

TG Therapeutics, Inc. (TGTX)

$7.95B

4.61x

4.63x

3.56x

-5.09x

Caris Life Sciences, Inc. (CAI)vs ›

$7.75B

0.79x

1.52x

Praxis Precision Medicines, Inc. (PRAX)vs ›

$7.61B

N/A

HealthEquity, Inc. (HQY)vs ›

$7.61B

5.64x

4.71x

3.13x

2.65x

Cytokinetics, Incorporated (CYTK)vs ›

$7.60B

-5.89x

8.36x

Hinge Health, Inc. (HNGE)vs ›

$7.57B

N/A

Oscar Health, Inc. (OSCR)vs ›

$8.39B

-22.52x

2.41x

Kymera Therapeutics, Inc. (KYMR)vs ›

$8.61B

-1403.21x

N/A

Ionis Pharmaceuticals, Inc. (IONS)vs ›

$7.25B

-4.22x

7.50x

4.09x

Arrowhead Pharmaceuticals, Inc. (ARWR)vs ›

$8.63B

1.10x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for TG Therapeutics, Inc. (TGTX)?

The interest coverage ratio for TGTX stock is 4.61x.

Is TG Therapeutics, Inc.'s interest coverage ratio high or low?

The interest coverage ratio of 4.61x is 191% above its 5-year average of -5.09x, near the high end of its 5-year range (-86.14x–30.91x).

What is the TTM average interest coverage ratio for TG Therapeutics, Inc. (TGTX)?

The TTM average interest coverage ratio for TGTX stock is 4.63x.

What is the 3Y average interest coverage ratio for TG Therapeutics, Inc. (TGTX)?

The 3Y average interest coverage ratio for TGTX stock is 3.56x.

What is the 5Y average interest coverage ratio for TG Therapeutics, Inc. (TGTX)?

The 5Y average interest coverage ratio for TGTX stock is -5.09x.

What is the 10Y average interest coverage ratio for TG Therapeutics, Inc. (TGTX)?

The 10Y average interest coverage ratio for TGTX stock is -24.27x.

What is the 15Y average interest coverage ratio for TG Therapeutics, Inc. (TGTX)?

The 15Y average interest coverage ratio for TGTX stock is -29.36x.

What is the 20Y average interest coverage ratio for TG Therapeutics, Inc. (TGTX)?

The 20Y average interest coverage ratio for TGTX stock is -25.62x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	1.31x
2026-03-31	4.54x
2025-12-31	7.73x
2025-09-30	4.37x
2025-06-30	5.19x
2025-03-31	1.28x
2024-12-31	4.24x
2024-09-30	1.15x
2024-06-30	2.22x
2024-03-31	-4.05x
2023-12-31	-5.14x
2023-09-30	30.91x
2023-06-30	-12.32x
2023-03-31	-13.01x
2022-12-31	-18.19x
2022-09-30	-21.22x
2022-06-30	-12.91x
2022-03-31	-25.10x
2021-12-31	-86.14x
2021-09-30	-82.01x
2021-06-30	-47.75x
2021-03-31	-47.00x
2020-12-31	-67.22x
2020-09-30	-53.24x
2020-06-30	-22.82x
2020-03-31	-41.84x
2019-12-31	-19.99x
2019-09-30	-39.60x
2019-06-30	-33.00x
2019-03-31	-44.82x
2018-09-30	-155.33x
2018-06-30	-198.86x
2016-09-30	-117.83x
2015-12-31	-72.88x
2015-09-30	-56.08x
2015-06-30	-69.41x
2015-03-31	-61.45x
2014-12-31	-79.74x
2014-09-30	-74.28x
2014-06-30	-50.92x
2014-03-31	-33.60x
2013-12-31	-33.11x
2013-09-30	-19.32x
2013-06-30	-27.62x
2013-03-31	-16.05x
2012-12-31	-16.12x
2012-09-30	-11.87x
2012-06-30	-13.61x
2012-03-31	-78.97x
2011-12-31	0.10x
2011-09-30	-0.22x
2011-06-30	-0.75x
2011-03-31	-1.95x
2010-12-31	-1.34x
2010-09-30	-1.48x
2010-06-30	-1.50x
2010-03-31	-2.24x
2009-12-31	-2.25x
2009-09-30	-2.89x
2009-06-30	-3.55x
2009-03-31	-4.44x
2008-12-31	0.81x
2008-09-30	-73.58x
2007-12-31	-4031.00x
2006-09-30	-2752.73x
2006-06-30	-9904.60x

DATE

INTEREST COVERAGE RATIO

2026-06-30

1.31x

2026-03-31

4.54x

2025-12-31

7.73x

2025-09-30

4.37x

2025-06-30

5.19x

2025-03-31

1.28x

2024-12-31

4.24x

2024-09-30

1.15x

2024-06-30

2.22x

2024-03-31

-4.05x

2023-12-31

-5.14x

2023-09-30

30.91x

2023-06-30

-12.32x

2023-03-31

-13.01x

2022-12-31

-18.19x

2022-09-30

-21.22x

2022-06-30

-12.91x

2022-03-31

-25.10x

2021-12-31

-86.14x

2021-09-30

-82.01x

2021-06-30

-47.75x

2021-03-31

-47.00x

2020-12-31

-67.22x

2020-09-30

-53.24x

2020-06-30

-22.82x

2020-03-31

-41.84x

2019-12-31

-19.99x

2019-09-30

-39.60x

2019-06-30

-33.00x

2019-03-31

-44.82x

2018-09-30

-155.33x

2018-06-30

-198.86x

2016-09-30

-117.83x

2015-12-31

-72.88x

2015-09-30

-56.08x

2015-06-30

-69.41x

2015-03-31

-61.45x

2014-12-31

-79.74x

2014-09-30

-74.28x

2014-06-30

-50.92x

2014-03-31

-33.60x

2013-12-31

-33.11x

2013-09-30

-19.32x

2013-06-30

-27.62x

2013-03-31

-16.05x

2012-12-31

-16.12x

2012-09-30

-11.87x

2012-06-30

-13.61x

2012-03-31

-78.97x

2011-12-31

0.10x

2011-09-30

-0.22x

2011-06-30

-0.75x

2011-03-31

-1.95x

2010-12-31

-1.34x

2010-09-30

-1.48x

2010-06-30

-1.50x

2010-03-31

-2.24x

2009-12-31

-2.25x

2009-09-30

-2.89x

2009-06-30

-3.55x

2009-03-31

-4.44x

2008-12-31

0.81x

2008-09-30

-73.58x

2007-12-31

-4031.00x

2006-09-30

-2752.73x

2006-06-30

-9904.60x

Interest Coverage Ratio: 4.61x

TGTX Interest Coverage Ratio

TGTX Average Interest Coverage Ratio Chart

TGTX Current vs Average Interest Coverage Ratio Chart

TGTX Interest Coverage Ratio Metrics

TGTX Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

TGTX Interest Coverage Ratio History

Related Metrics